Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.
de Lucas R, Moreno-Arias G, Perez-López M, Vera-Casaño Á, Aladren S, Milani M; ACTUO Investigators study group. de Lucas R, et al. Among authors: milani m. BMC Dermatol. 2015 Sep 11;15:17. doi: 10.1186/s12895-015-0036-8. BMC Dermatol. 2015. PMID: 26361978 Free PMC article.
An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controlled trial.
Federici A, Federici G, Milani M. Federici A, et al. Among authors: milani m. BMC Dermatol. 2012 Sep 25;12:16. doi: 10.1186/1471-5945-12-16. BMC Dermatol. 2012. PMID: 23009311 Free PMC article. Clinical Trial.
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study.
Serini SM, Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Ventura A, Milani M, Campione E, Bianchi L. Serini SM, et al. Among authors: milani m. J Cosmet Dermatol. 2019 Feb;18(1):156-162. doi: 10.1111/jocd.12670. Epub 2018 May 22. J Cosmet Dermatol. 2019. PMID: 29790262 Clinical Trial.
Efficacy and tolerability of a cream containing modified glutathione (GSH-C4), beta-Glycyrrhetic, and azelaic acids in mild-to-moderate rosacea: A pilot, assessor-blinded, VISIA and ANTERA 3-D analysis, two-center study (The "Rosazel" Trial).
Dall'Oglio F, Puviani M, Milani M, Micali G. Dall'Oglio F, et al. Among authors: milani m. J Cosmet Dermatol. 2021 Apr;20(4):1197-1203. doi: 10.1111/jocd.13707. Epub 2020 Sep 21. J Cosmet Dermatol. 2021. PMID: 32885541
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A, Ruffinazzi G, DE Filippo M, Castagnoli R, Marseglia A, Agostinis F, Puviani M, Milani M, Marseglia GL. Licari A, et al. Among authors: milani m. Minerva Pediatr. 2017 Dec;69(6):470-475. doi: 10.23736/S0026-4946.17.05015-0. Minerva Pediatr. 2017. PMID: 29181960 Clinical Trial.
775 results